Celgene | Search Results | Sutro Biopharma, Inc.

New Search

If you are not happy with the results below please do another search

Sutro Biopharma to Present at 38th Annual J.P. Morgan Healthcare Conference

January 9, 2020

SOUTH SAN FRANCISCO, Calif., Jan. 8, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and... read more →

Sutro Biopharma Appoints James Panek to Board of Directors

January 8, 2020

Sutro Biopharma to Participate in the 31st Annual Piper Jaffray Healthcare Conference

November 26, 2019

SOUTH SAN FRANCISCO, Calif., Nov. 26, 2019 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and... read more →

Sutro Biopharma to Present at the Stifel 2019 Healthcare Conference

November 19, 2019

SOUTH SAN FRANCISCO, Calif., Nov. 19, 2019 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and... read more →

Sutro Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights and Developments

November 8, 2019

STRO-002 Initial Safety Data from an Ongoing Phase 1 Trial in Ovarian and Endometrial Cancers presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 29, 2019 STRO-001... read more →

Sutro Biopharma to Present at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

October 29, 2019

Sutro Biopharma Presents Encouraging Preliminary Clinical Data in Ongoing Phase I Study for STRO-002 Antibody-Drug Conjugate in Patients with Advanced Ovarian Cancer - Data is being presented as a poster... read more →

Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

October 16, 2019

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2019 – Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that the company will present at the upcoming AACR-NCI-EORTC International Conference on Molecular Targets and... read more →

35 Search results for: Celgene